Table 2
Age-standardized mortality rates (ASMRs) per 100,000 person-years at risk for selected causes of death, by income adequacy quintile (Q1 to Q5), male cohort members aged 25 or older at baseline, Canada, 1991 to 2006

Table 2
Age-standardized mortality rates (ASMRs) per 100,000 person-years at risk for selected causes of death, by income adequacy quintile (Q1 to Q5), male cohort members aged 25 or older at baseline, Canada, 1991 to 2006
Table summary
This table displays the results of age-standardized mortality rates (asmrs) per 100. The information is grouped by cause of death (appearing as row headers), asmr, rr, rd, excess and % excess , calculated using total, q1 (lowest), q2, q3, q4 and q5 (highest) units of measure (appearing as column headers).
Cause of death ASMR RR RD Excess % excess
Total Q1 (lowest) Q2 Q3 Q4 Q5 (highest)
All causes 1,372.8 1,850.2 1,494.4 1,337.7 1,236.2 1,105.9 1.67Note * 744.4Note * 266.9 19.4
Communicable diseases 57.7 83.3 62.9 54.9 51.2 45.1 1.85Note * 38.2Note * 12.6 21.9
HIV/AIDS 5.8 12.7 7.4 4.3 4.4 3.6 3.57Note * 9.1Note * 2.2 38.7
Respiratory infections 36.4 47.0 38.8 35.5 33.4 29.2 1.61Note * 17.8Note * 7.2 19.8
Non-communicable diseases 1,187.8 1,567.5 1,295.9 1,166.7 1,073.2 958.7 1.64Note * 608.8Note * 229.0 19.3
Malignant neoplasms 416.5 510.4 450.1 423.6 386.8 348.6 1.46Note * 161.8Note * 67.9 16.3
Stomach cancer 15.5 18.4 18.1 15.2 14.2 12.6 1.46Note * 5.8Note * 2.9 19.0
Colon and rectal cancers 44.0 50.0 45.3 45.0 42.5 38.5 1.30Note * 11.6Note * 5.5 12.6
Liver cancer 9.0 12.9 9.6 8.7 8.6 7.1 1.80Note * 5.7Note * 1.9 21.1
Pancreatic cancer 19.9 20.9 20.5 19.8 19.9 18.7 1.12Note * 2.2Note * 1.3 6.4
Trachea, bronchus, and lung cancers 124.1 177.7 147.3 126.2 104.2 83.9 2.12Note * 93.8Note * 40.2 32.4
Prostate cancer 51.7 51.6 54.0 53.2 51.0 48.3 1.07 3.3 3.3 6.5
Diabetes mellitus 38.3 61.0 43.0 37.4 33.3 24.5 2.49Note * 36.6Note * 13.8 36.0
Neuropsychiatric conditions 65.7 87.0 67.2 62.4 60.8 60.7 1.43Note * 26.3Note * 5.0 7.6
Alcohol use disorders 5.0 14.5 4.9 3.7 3.2 2.5 5.76Note * 12.0Note * 2.5 49.7
Alzheimer’s disease and other dementias 32.9 35.9 34.1 32.4 30.5 32.4 1.11Note * 3.4Note * 0.4 1.4
Cardiovascular diseases 483.4 640.2 529.3 467.1 432.9 393.1 1.63Note * 247.0Note * 90.3 18.7
Ischemic heart disease 293.3 394.8 323.9 281.6 261.9 233.2 1.69Note * 161.6Note * 60.1 20.5
Cerebrovascular disease 79.3 102.6 84.7 78.0 70.8 66.6 1.54Note * 36.0Note * 12.6 15.9
Respiratory diseases 86.0 125.3 100.0 82.0 73.9 54.3 2.31Note * 70.9Note * 31.7 36.9
Chronic obstructive pulmonary disease 65.4 98.7 78.5 61.7 53.9 36.2 2.73Note * 62.5Note * 29.3 44.7
Digestive diseases 46.5 75.7 51.2 43.0 39.5 35.0 2.16Note * 40.7Note * 11.5 24.7
Cirrhosis of the liver 15.1 28.9 17.3 13.4 11.7 10.6 2.74Note * 18.4Note * 4.5 29.9
Injuries 71.9 112.4 76.2 67.0 65.4 58.5 1.92Note * 53.8Note * 13.3 18.6
Unintentional injuries 45.7 68.2 47.6 42.7 42.5 39.6 1.72Note * 28.6Note * 6.2 13.5
Road traffic accidents 12.5 17.6 12.7 11.2 11.6 11.7 1.50Note * 5.9Note * 0.8 6.8
Intentional injuries 24.4 40.1 26.9 22.8 21.7 18.0 2.23Note * 22.1Note * 6.4 26.3
Suicide 22.7 35.1 24.8 21.2 21.2 17.2 2.04Note * 17.9Note * 5.5 24.4
Smoking-related diseases 216.2 318.5 254.2 213.0 183.2 140.0 2.27Note * 178.5Note * 76.2 35.2
Alcohol-related diseases 15.8 36.9 17.4 13.1 11.3 9.7 3.81Note * 27.2Note * 6.2 38.9
Drug-related diseases 5.4 14.8 5.8 4.1 3.6 3.4 4.31Note * 11.4Note * 2.1 46.4
Amenable to medical intervention (younger than age 75) 51.6 93.1 59.6 47.3 42.4 36.9 2.52Note * 56.1Note * 14.7 28.4
Not amenable to medical intervention (younger than age 75) 518.1 835.8 586.9 507.1 454.5 380.9 2.19Note * 454.8Note * 137.2 26.5
Note *

significantly different from rate for quintile 5 (p < 0.05)

RR = inter-quintile rate ratio (Q1 / Q5)
RD = inter-quintile rate difference (Q1 - Q5)
Excess = (total - Q5)
% excess = [100 * (total - Q5)/total]
Note: Reference population (person-years at risk) for age-standardization was taken from the internal cohort age distribution (5-year age groups).
Source: 1991 to 2006 Canadian census mortality and cancer follow-up study.
Date modified: